Clinical Trial: Clinical Investigation to Validate the Safety and Performance of the ABLE Exoskeleton Device for Individuals With Acquired Brain Injury in a Clinical Setting

U.S., July 4 -- ClinicalTrials.gov registry received information related to the study (NCT07050875) titled 'Clinical Investigation to Validate the Safety and Performance of the ABLE Exoskeleton Device for Individuals With Acquired Brain Injury in a Clinical Setting' on June 16.

Brief Summary: The primary objective of the study is to validate the safety and clinical performance of the ABLE Exoskeleton device in people with acquired brain injury during a 10-session gait training program in a clinical setting.

The secondary objective of the study focuses on obtaining preliminary data on the potential clinical and psychosocial benefits of the product.

Study Start Date: June 30

Study Type: INTERVENTIONAL

Condition: Acquired Brain Injury (I...